跳至主要内容
临床试验/ACTRN12612000410853
ACTRN12612000410853招募中未知

Response of Patients with Chronic Obstructive Pulmonary Disease to Airvo, as Measured by Carbon Dioxide Levels

Richard Beasley0 个研究点目标入组 18 人开始时间: 2012年4月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of chronic obstructive pulmonary disease with baseline oxygen saturations of 85-92%. A raise in transcutaneous carbon dioxide of greater than or equal to 4mmHg on eligibility testing (50% oxygen administration via a mask until transcutaneous carbon dioxide increases by greater than or equal to 4mmHg or for 20 minutes).

排除标准

  • An intercurrent chest infection
  • FEV1>50% predicted
  • FEV1:FVC >0.7
  • Baseline transcutaneous carbon dioxide of greater than 60mmHg
  • Diagnosis of a disease causing restriction to chest wall expansion (neuromuscular disease or chest wall dysfunction)
  • Obesity (body mass index greater than or equal to 40)
  • Inability to tolerate the Airvo device at 25 and 45 Litres per minute
  • Any other condition which, at the investigator's discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

研究者

发起方
Richard Beasley

相似试验

The Airvo Device and Oxygen Administration in... | 临床试验